Everything We’re Saying, and Everything Being Said About Us
Explore the stories behind our science and the people it serves.
Subscribe to Our Monthly Newsletter
Each month, we will send key data updates, stories from the field, and new research on inclusive oncology AI.

New Study: AI Reveals Hidden Subgroup in Endometrial Cancer
A new study has demonstrated the power of artificial intelligence (AI) in enhancing our understanding of endometrial cancer (EC), particularly...

PAICON at the 9th Healthcare Symposium: From Data to Diagnostics
PAICON recently took part in the 9th Healthcare Symposium in Berlin, where our Managing Director Danny Quick delivered a compelling...

Our Managing Director Presents at the 9th Healthcare Symposium
Danny Quick, Managing Director at PAICON, presents on AI in diagnostics at the 9th Healthcare Symposium organized by Arvato Systems....

Understanding the Impact of Unbiased Data for AI in Healthcare
In today’s world of data-driven medicine, the quality of information is everything. Unbiased data forms the foundation of fair, effective,...

PAICON Summer Party
Our recent summer party was a wonderful celebration of the values that define our company.

PAICON at MIDL2024: Advancing AI in Medical Imaging
The MIDL2024 conference in Paris was exceptionally well-organized, focusing on groundbreaking advancements in medical imaging.

PAICON Company Retreat Recap
Our recent company retreat at Strotzbüscher Mühle was a valuable experience for our team.

PAICON SatSight DX for Rapid MSI Detection in Colorectal Cancer
Microsatellite instability (MSI) is a critical biomarker in colorectal cancer (CRC), influencing diagnosis, prognosis, and treatment decisions. Traditional MSI detection...

PAICON Shines at Health.Tech 2024 with AI Solutions
Attending the Health.Tech Conference in Munich was a major milestone for PAICON.
Subscribe to Our Monthly Newsletter
Each month, we will send key data updates, stories from the field, and
new research on
inclusive oncology AI.
We respect your privacy. Unsubscribe at any time.